Adagio Medical Holdings, Inc. (NASDAQ: ADGM) Stock Competitors & Peer Comparison
See ADGM's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ADGM and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADGM | $0.48 | -0.08% | 10.7M | -0.32 | -$1.53 | N/A |
| ABT | $104.49 | +1.39% | 182.2B | 20.07 | $5.21 | +2.37% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $336.74 | +1.97% | 129.1B | 25.16 | $13.39 | +1.03% |
| ISRG | $356.83 | +5.73% | 126.1B | 37.09 | $9.62 | N/A |
| MDT | $84.22 | +1.21% | 107.8B | 15.23 | $5.53 | +3.38% |
| BSX | $45.51 | +2.85% | 67.6B | 14.68 | $3.10 | N/A |
| EW | $83.04 | +0.50% | 47.8B | 30.74 | $2.70 | N/A |
| RMD | $203.08 | +4.00% | 29.5B | 18.86 | $10.77 | +1.18% |
| DXCM | $73.37 | +2.56% | 28.3B | 31.49 | $2.33 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
ADGM vs ABT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ABT has a market cap of 182.2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ABT trades at $104.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ABT's P/E ratio is 20.07. In terms of profitability, ADGM's ROE is -3.82%, compared to ABT's ROE of +0.11%. Regarding short-term risk, ADGM is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
ADGM vs BSX-PA Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ADGM's ROE is -3.82%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, ADGM is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
ADGM vs SYK Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SYK has a market cap of 129.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SYK trades at $336.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SYK's P/E ratio is 25.16. In terms of profitability, ADGM's ROE is -3.82%, compared to SYK's ROE of +0.15%. Regarding short-term risk, ADGM is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SYK's competition here
Intuitive Surgical, Inc. (NASDAQ: ISRG)
ADGM vs ISRG Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ISRG has a market cap of 126.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ISRG trades at $356.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ISRG's P/E ratio is 37.09. In terms of profitability, ADGM's ROE is -3.82%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, ADGM is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ISRG's competition here
Medtronic plc (NYSE: MDT)
ADGM vs MDT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, MDT has a market cap of 107.8B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while MDT trades at $84.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas MDT's P/E ratio is 15.23. In terms of profitability, ADGM's ROE is -3.82%, compared to MDT's ROE of +0.10%. Regarding short-term risk, ADGM is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
ADGM vs BSX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BSX has a market cap of 67.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BSX trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BSX's P/E ratio is 14.68. In terms of profitability, ADGM's ROE is -3.82%, compared to BSX's ROE of +0.15%. Regarding short-term risk, ADGM is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
ADGM vs EW Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, EW has a market cap of 47.8B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while EW trades at $83.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas EW's P/E ratio is 30.74. In terms of profitability, ADGM's ROE is -3.82%, compared to EW's ROE of +0.10%. Regarding short-term risk, ADGM is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check EW's competition here
ResMed Inc. (NYSE: RMD)
ADGM vs RMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, RMD has a market cap of 29.5B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while RMD trades at $203.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas RMD's P/E ratio is 18.86. In terms of profitability, ADGM's ROE is -3.82%, compared to RMD's ROE of +0.24%. Regarding short-term risk, ADGM is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check RMD's competition here
DexCom, Inc. (NASDAQ: DXCM)
ADGM vs DXCM Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, DXCM has a market cap of 28.3B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while DXCM trades at $73.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas DXCM's P/E ratio is 31.49. In terms of profitability, ADGM's ROE is -3.82%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, ADGM is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
ADGM vs ZBH Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ZBH has a market cap of 17.8B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ZBH trades at $92.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ZBH's P/E ratio is 10.85. In terms of profitability, ADGM's ROE is -3.82%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, ADGM is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
ADGM vs ABMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ADGM's ROE is -3.82%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ADGM is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ABMD's competition here
Smith & Nephew plc (NYSE: SNN)
ADGM vs SNN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SNN has a market cap of 13.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SNN trades at $31.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SNN's P/E ratio is 16.82. In terms of profitability, ADGM's ROE is -3.82%, compared to SNN's ROE of +0.12%. Regarding short-term risk, ADGM is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
ADGM vs PEN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while PEN trades at $319.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas PEN's P/E ratio is 83.43. In terms of profitability, ADGM's ROE is -3.82%, compared to PEN's ROE of +0.12%. Regarding short-term risk, ADGM is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
ADGM vs SWAV Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ADGM's ROE is -3.82%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, ADGM is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
ADGM vs ALGN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ALGN has a market cap of 12B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ALGN trades at $168.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ALGN's P/E ratio is 15.32. In terms of profitability, ADGM's ROE is -3.82%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, ADGM is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ALGN's competition here
Insulet Corp. (NASDAQ: PODD)
ADGM vs PODD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, PODD has a market cap of 11.4B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while PODD trades at $165.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas PODD's P/E ratio is 30.67. In terms of profitability, ADGM's ROE is -3.82%, compared to PODD's ROE of +0.21%. Regarding short-term risk, ADGM is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check PODD's competition here
Globus Medical, Inc. (NYSE: GMED)
ADGM vs GMED Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, GMED has a market cap of 10.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while GMED trades at $78.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas GMED's P/E ratio is 17.62. In terms of profitability, ADGM's ROE is -3.82%, compared to GMED's ROE of +0.13%. Regarding short-term risk, ADGM is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
ADGM vs MASI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas MASI's P/E ratio is 44.43. In terms of profitability, ADGM's ROE is -3.82%, compared to MASI's ROE of +0.09%. Regarding short-term risk, ADGM is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
ADGM vs BRKR Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BRKR has a market cap of 9.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BRKR trades at $60.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BRKR's P/E ratio is 32.99. In terms of profitability, ADGM's ROE is -3.82%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, ADGM is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check BRKR's competition here
Glaukos Corporation (NYSE: GKOS)
ADGM vs GKOS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, GKOS has a market cap of 8.9B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while GKOS trades at $151.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas GKOS's P/E ratio is -176.67. In terms of profitability, ADGM's ROE is -3.82%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, ADGM is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
ADGM vs BIO-B Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BIO-B has a market cap of 8.8B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BIO-B trades at $320.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BIO-B's P/E ratio is 95.01. In terms of profitability, ADGM's ROE is -3.82%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, ADGM is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
ADGM vs BIO Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BIO has a market cap of 8.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BIO trades at $316.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BIO's P/E ratio is 34.13. In terms of profitability, ADGM's ROE is -3.82%, compared to BIO's ROE of +0.02%. Regarding short-term risk, ADGM is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check BIO's competition here
Inari Medical, Inc. (NASDAQ: NARI)
ADGM vs NARI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas NARI's P/E ratio is -59.24. In terms of profitability, ADGM's ROE is -3.82%, compared to NARI's ROE of -0.00%. Regarding short-term risk, ADGM is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
ADGM vs LIVN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while LIVN trades at $80.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas LIVN's P/E ratio is 20.15. In terms of profitability, ADGM's ROE is -3.82%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, ADGM is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
ADGM vs IRTC Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while IRTC trades at $112.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas IRTC's P/E ratio is -200.27. In terms of profitability, ADGM's ROE is -3.82%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, ADGM is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
ADGM vs AXNX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ADGM's ROE is -3.82%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ADGM is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check AXNX's competition here
Integer Holdings Corporation (NYSE: ITGR)
ADGM vs ITGR Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ITGR has a market cap of 3.4B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ITGR trades at $99.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ITGR's P/E ratio is 15.79. In terms of profitability, ADGM's ROE is -3.82%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, ADGM is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ITGR's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
ADGM vs ESTA Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ESTA has a market cap of 2.7B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ESTA trades at $92.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ESTA's P/E ratio is -63.96. In terms of profitability, ADGM's ROE is -3.82%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, ADGM is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ESTA's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
ADGM vs TMDX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, TMDX has a market cap of 2.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while TMDX trades at $74.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas TMDX's P/E ratio is 30.37. In terms of profitability, ADGM's ROE is -3.82%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, ADGM is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
ADGM vs AXGN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, AXGN has a market cap of 2.2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while AXGN trades at $41.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas AXGN's P/E ratio is 108.26. In terms of profitability, ADGM's ROE is -3.82%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, ADGM is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
ADGM vs NUVA Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ADGM's ROE is -3.82%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ADGM is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
ADGM vs NVCR Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while NVCR trades at $17.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas NVCR's P/E ratio is -11.13. In terms of profitability, ADGM's ROE is -3.82%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, ADGM is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check NVCR's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
ADGM vs UFPT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while UFPT trades at $248.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas UFPT's P/E ratio is 25.90. In terms of profitability, ADGM's ROE is -3.82%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, ADGM is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
ADGM vs BFLY Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BFLY has a market cap of 1.9B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BFLY trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BFLY's P/E ratio is -29.52. In terms of profitability, ADGM's ROE is -3.82%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, ADGM is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
ADGM vs ENOV Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ENOV trades at $28.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ENOV's P/E ratio is 8.36. In terms of profitability, ADGM's ROE is -3.82%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, ADGM is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
ADGM vs IART Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, IART has a market cap of 1.5B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while IART trades at $19.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas IART's P/E ratio is 8.28. In terms of profitability, ADGM's ROE is -3.82%, compared to IART's ROE of -0.48%. Regarding short-term risk, ADGM is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check IART's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
ADGM vs AHCO Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, AHCO has a market cap of 1.5B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while AHCO trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas AHCO's P/E ratio is 24.91. In terms of profitability, ADGM's ROE is -3.82%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, ADGM is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check AHCO's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
ADGM vs INSP Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, INSP has a market cap of 1.5B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while INSP trades at $50.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas INSP's P/E ratio is 19.75. In terms of profitability, ADGM's ROE is -3.82%, compared to INSP's ROE of +0.18%. Regarding short-term risk, ADGM is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check INSP's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
ADGM vs ATEC Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ATEC has a market cap of 1.3B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ATEC trades at $8.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ATEC's P/E ratio is -78.82. In terms of profitability, ADGM's ROE is -3.82%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, ADGM is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
ADGM vs CNMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CNMD has a market cap of 1.3B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CNMD trades at $43.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CNMD's P/E ratio is 9.57. In terms of profitability, ADGM's ROE is -3.82%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, ADGM is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
ADGM vs HSKA Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ADGM's ROE is -3.82%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ADGM is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check HSKA's competition here
Artivion, Inc. (NYSE: AORT)
ADGM vs AORT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while AORT trades at $26.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas AORT's P/E ratio is 40.15. In terms of profitability, ADGM's ROE is -3.82%, compared to AORT's ROE of +0.03%. Regarding short-term risk, ADGM is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
ADGM vs IRMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while IRMD trades at $95.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas IRMD's P/E ratio is 47.78. In terms of profitability, ADGM's ROE is -3.82%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, ADGM is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
ADGM vs TNDM Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while TNDM trades at $17.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas TNDM's P/E ratio is -15.61. In terms of profitability, ADGM's ROE is -3.82%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, ADGM is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
ADGM vs AVNS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas AVNS's P/E ratio is 27.77. In terms of profitability, ADGM's ROE is -3.82%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, ADGM is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
ADGM vs SILK Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SILK's P/E ratio is -18.96. In terms of profitability, ADGM's ROE is -3.82%, compared to SILK's ROE of -0.35%. Regarding short-term risk, ADGM is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
ADGM vs FNA Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas FNA's P/E ratio is -19.83. In terms of profitability, ADGM's ROE is -3.82%, compared to FNA's ROE of -0.35%. Regarding short-term risk, ADGM is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check FNA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
ADGM vs LMRI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while LMRI trades at $11.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas LMRI's P/E ratio is -21.50. In terms of profitability, ADGM's ROE is -3.82%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, ADGM is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
ADGM vs PRCT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while PRCT trades at $17.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas PRCT's P/E ratio is -9.72. In terms of profitability, ADGM's ROE is -3.82%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, ADGM is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check PRCT's competition here
InMode Ltd. (NASDAQ: INMD)
ADGM vs INMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, INMD has a market cap of 884.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while INMD trades at $15.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas INMD's P/E ratio is 9.86. In terms of profitability, ADGM's ROE is -3.82%, compared to INMD's ROE of +0.13%. Regarding short-term risk, ADGM is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
ADGM vs CSII Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CSII's P/E ratio is -20.83. In terms of profitability, ADGM's ROE is -3.82%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ADGM is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CSII's competition here
Bioventus Inc. (NASDAQ: BVS)
ADGM vs BVS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BVS has a market cap of 843.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BVS trades at $12.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BVS's P/E ratio is 16.60. In terms of profitability, ADGM's ROE is -3.82%, compared to BVS's ROE of +0.16%. Regarding short-term risk, ADGM is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check BVS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
ADGM vs SSII Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SSII has a market cap of 792.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SSII trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SSII's P/E ratio is -77.24. In terms of profitability, ADGM's ROE is -3.82%, compared to SSII's ROE of -0.23%. Regarding short-term risk, ADGM is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check SSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
ADGM vs SIBN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SIBN has a market cap of 756.2M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SIBN trades at $17.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SIBN's P/E ratio is -43.72. In terms of profitability, ADGM's ROE is -3.82%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, ADGM is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SIBN's competition here
CeriBell, Inc. (NASDAQ: CBLL)
ADGM vs CBLL Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CBLL has a market cap of 687.9M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CBLL trades at $18.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CBLL's P/E ratio is -11.12. In terms of profitability, ADGM's ROE is -3.82%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, ADGM is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
ADGM vs TCMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, TCMD has a market cap of 626.2M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while TCMD trades at $27.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas TCMD's P/E ratio is 31.55. In terms of profitability, ADGM's ROE is -3.82%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, ADGM is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check TCMD's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
ADGM vs BWAY Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BWAY has a market cap of 618.2M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BWAY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BWAY's P/E ratio is 40.04. In terms of profitability, ADGM's ROE is -3.82%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, ADGM is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check BWAY's competition here
Cerus Corporation (NASDAQ: CERS)
ADGM vs CERS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CERS has a market cap of 615.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CERS trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CERS's P/E ratio is -61.28. In terms of profitability, ADGM's ROE is -3.82%, compared to CERS's ROE of -0.15%. Regarding short-term risk, ADGM is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CERS's competition here
Surmodics, Inc. (NASDAQ: SRDX)
ADGM vs SRDX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SRDX's P/E ratio is -34.66. In terms of profitability, ADGM's ROE is -3.82%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, ADGM is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
ADGM vs APEN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas APEN's P/E ratio is -9.43. In terms of profitability, ADGM's ROE is -3.82%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ADGM is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
ADGM vs CTKB Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CTKB has a market cap of 569.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CTKB trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CTKB's P/E ratio is -33.92. In terms of profitability, ADGM's ROE is -3.82%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, ADGM is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
ADGM vs ZIMV Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, ADGM's ROE is -3.82%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, ADGM is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ZIMV's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
ADGM vs NPCE Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, NPCE has a market cap of 521.6M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while NPCE trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas NPCE's P/E ratio is -26.38. In terms of profitability, ADGM's ROE is -3.82%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, ADGM is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check NPCE's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
ADGM vs KIDS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, KIDS has a market cap of 509.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while KIDS trades at $19.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas KIDS's P/E ratio is -19.24. In terms of profitability, ADGM's ROE is -3.82%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, ADGM is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check KIDS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
ADGM vs OFIX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, OFIX has a market cap of 481M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while OFIX trades at $11.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas OFIX's P/E ratio is -48.47. In terms of profitability, ADGM's ROE is -3.82%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, ADGM is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check OFIX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
ADGM vs VREX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, VREX has a market cap of 462.3M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while VREX trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas VREX's P/E ratio is 11.56. In terms of profitability, ADGM's ROE is -3.82%, compared to VREX's ROE of -0.18%. Regarding short-term risk, ADGM is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check VREX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
ADGM vs CLPT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CLPT has a market cap of 437.8M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CLPT trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CLPT's P/E ratio is -14.46. In terms of profitability, ADGM's ROE is -3.82%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, ADGM is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
ADGM vs PACB Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, PACB has a market cap of 422.4M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while PACB trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas PACB's P/E ratio is -2.78. In terms of profitability, ADGM's ROE is -3.82%, compared to PACB's ROE of -4.88%. Regarding short-term risk, ADGM is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
ADGM vs DCTH Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, DCTH has a market cap of 412.2M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while DCTH trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas DCTH's P/E ratio is 1194.00. In terms of profitability, ADGM's ROE is -3.82%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, ADGM is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check DCTH's competition here
Electromed, Inc. (AMEX: ELMD)
ADGM vs ELMD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ELMD has a market cap of 330.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ELMD trades at $39.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ELMD's P/E ratio is 34.12. In terms of profitability, ADGM's ROE is -3.82%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, ADGM is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ELMD's competition here
Carlsmed, Inc. (NASDAQ: CARL)
ADGM vs CARL Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CARL has a market cap of 311.3M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CARL trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CARL's P/E ratio is -4.56. In terms of profitability, ADGM's ROE is -3.82%, compared to CARL's ROE of -0.62%. Regarding short-term risk, ADGM is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CARL's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
ADGM vs SMLR Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SMLR's P/E ratio is 3.92. In terms of profitability, ADGM's ROE is -3.82%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, ADGM is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SMLR's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
ADGM vs AVR Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, AVR has a market cap of 300.6M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while AVR trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas AVR's P/E ratio is -3.66. In terms of profitability, ADGM's ROE is -3.82%, compared to AVR's ROE of -1.24%. Regarding short-term risk, ADGM is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check AVR's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
ADGM vs SGHT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SGHT has a market cap of 278.6M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SGHT trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SGHT's P/E ratio is -7.21. In terms of profitability, ADGM's ROE is -3.82%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, ADGM is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SGHT's competition here
Profound Medical Corp. (NASDAQ: PROF)
ADGM vs PROF Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, PROF has a market cap of 266.4M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while PROF trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas PROF's P/E ratio is -5.91. In terms of profitability, ADGM's ROE is -3.82%, compared to PROF's ROE of -0.70%. Regarding short-term risk, ADGM is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check PROF's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
ADGM vs TMCI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, TMCI has a market cap of 264.7M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while TMCI trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas TMCI's P/E ratio is -4.34. In terms of profitability, ADGM's ROE is -3.82%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, ADGM is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
ADGM vs MGRM Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas MGRM's P/E ratio is -12.00. In terms of profitability, ADGM's ROE is -3.82%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, ADGM is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check MGRM's competition here
RxSight, Inc. (NASDAQ: RXST)
ADGM vs RXST Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, RXST has a market cap of 233.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while RXST trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas RXST's P/E ratio is -7.83. In terms of profitability, ADGM's ROE is -3.82%, compared to RXST's ROE of -0.17%. Regarding short-term risk, ADGM is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check RXST's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
ADGM vs FOCL Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, FOCL has a market cap of 230.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while FOCL trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas FOCL's P/E ratio is -7.91. In terms of profitability, ADGM's ROE is -3.82%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, ADGM is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
ADGM vs NVRO Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ADGM's ROE is -3.82%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ADGM is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check NVRO's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
ADGM vs CATX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CATX has a market cap of 217.8M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CATX trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CATX's P/E ratio is -2.00. In terms of profitability, ADGM's ROE is -3.82%, compared to CATX's ROE of -0.42%. Regarding short-term risk, ADGM is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check CATX's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
ADGM vs SENS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SENS has a market cap of 209.4M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SENS trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SENS's P/E ratio is -2.50. In terms of profitability, ADGM's ROE is -3.82%, compared to SENS's ROE of -1.30%. Regarding short-term risk, ADGM is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
ADGM vs ANIK Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ANIK has a market cap of 199.9M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ANIK trades at $15.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ANIK's P/E ratio is 30.65. In terms of profitability, ADGM's ROE is -3.82%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, ADGM is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ANIK's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
ADGM vs BSGM Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas BSGM's P/E ratio is -5.81. In terms of profitability, ADGM's ROE is -3.82%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, ADGM is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
ADGM vs MDGS Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas MDGS's P/E ratio is -0.27. In terms of profitability, ADGM's ROE is -3.82%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, ADGM is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check MDGS's competition here
Quanterix Corporation (NASDAQ: QTRX)
ADGM vs QTRX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, QTRX has a market cap of 172.9M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while QTRX trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas QTRX's P/E ratio is -2.29. In terms of profitability, ADGM's ROE is -3.82%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, ADGM is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
ADGM vs INGN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, INGN has a market cap of 170.8M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while INGN trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas INGN's P/E ratio is -6.93. In terms of profitability, ADGM's ROE is -3.82%, compared to INGN's ROE of -0.13%. Regarding short-term risk, ADGM is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check INGN's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
ADGM vs TLSI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, TLSI has a market cap of 163.8M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while TLSI trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas TLSI's P/E ratio is -2.57. In terms of profitability, ADGM's ROE is -3.82%, compared to TLSI's ROE of +1.63%. Regarding short-term risk, ADGM is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check TLSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
ADGM vs QIPT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas QIPT's P/E ratio is -15.87. In terms of profitability, ADGM's ROE is -3.82%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, ADGM is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check QIPT's competition here
Picard Medical, Inc. (AMEX: PMI)
ADGM vs PMI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, PMI has a market cap of 137.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while PMI trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas PMI's P/E ratio is -0.07. In terms of profitability, ADGM's ROE is -3.82%, compared to PMI's ROE of +4.99%. Regarding short-term risk, ADGM is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check PMI's competition here
CVRx, Inc. (NASDAQ: CVRX)
ADGM vs CVRX Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, CVRX has a market cap of 129.5M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while CVRX trades at $4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas CVRX's P/E ratio is -2.42. In terms of profitability, ADGM's ROE is -3.82%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, ADGM is more volatile compared to CVRX. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check CVRX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
ADGM vs RCEL Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, RCEL has a market cap of 118M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while RCEL trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas RCEL's P/E ratio is -3.03. In terms of profitability, ADGM's ROE is -3.82%, compared to RCEL's ROE of +3.05%. Regarding short-term risk, ADGM is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check RCEL's competition here
Vivani Medical, Inc. (NASDAQ: VANI)
ADGM vs VANI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, VANI has a market cap of 112.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while VANI trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas VANI's P/E ratio is -3.25. In terms of profitability, ADGM's ROE is -3.82%, compared to VANI's ROE of -2.64%. Regarding short-term risk, ADGM is more volatile compared to VANI. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check VANI's competition here
iCAD, Inc. (NASDAQ: ICAD)
ADGM vs ICAD Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ICAD's P/E ratio is -20.37. In terms of profitability, ADGM's ROE is -3.82%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, ADGM is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
ADGM vs HJLI Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas HJLI's P/E ratio is N/A. In terms of profitability, ADGM's ROE is -3.82%, compared to HJLI's ROE of -0.66%. Regarding short-term risk, ADGM is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check HJLI's competition here
Solana Company (NASDAQ: HSDT)
ADGM vs HSDT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, HSDT has a market cap of 98.1M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while HSDT trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas HSDT's P/E ratio is -0.02. In terms of profitability, ADGM's ROE is -3.82%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, ADGM is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check HSDT's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
ADGM vs SKIN Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, SKIN has a market cap of 96.9M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while SKIN trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas SKIN's P/E ratio is -4.40. In terms of profitability, ADGM's ROE is -3.82%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, ADGM is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for ADGM.Check SKIN's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
ADGM vs ASXC Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas ASXC's P/E ratio is -1.12. In terms of profitability, ADGM's ROE is -3.82%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, ADGM is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check ASXC's competition here
Owlet, Inc. (NYSE: OWLT)
ADGM vs OWLT Comparison July 2026
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADGM stands at 10.7M. In comparison, OWLT has a market cap of 94.7M. Regarding current trading prices, ADGM is priced at $0.48 on the NASDAQ, while OWLT trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADGM currently has a P/E ratio of -0.32, whereas OWLT's P/E ratio is -37.38. In terms of profitability, ADGM's ROE is -3.82%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, ADGM is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for ADGM.Check OWLT's competition here